Integrated Diagnostics Holdings PLC - Asset Resilience Ratio
Integrated Diagnostics Holdings PLC (IDHC) has an Asset Resilience Ratio of 5.46% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Integrated Diagnostics Holdings PLC to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Integrated Diagnostics Holdings PLC's Asset Resilience Ratio has changed over time. See Integrated Diagnostics Holdings PLC (IDHC) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Integrated Diagnostics Holdings PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Integrated Diagnostics Holdings PLC market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $408.89 Million | 5.46% |
| Total Liquid Assets | $408.89 Million | 5.46% |
Asset Resilience Insights
- Limited Liquidity: Integrated Diagnostics Holdings PLC maintains only 5.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Integrated Diagnostics Holdings PLC Industry Peers by Asset Resilience Ratio
Compare Integrated Diagnostics Holdings PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 16.06% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.12% |
|
Spectral Med Inc
TO:EDT |
Diagnostics & Research | 11.67% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Genetic Signatures Ltd
AU:GSS |
Diagnostics & Research | 60.91% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Integrated Diagnostics Holdings PLC (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Integrated Diagnostics Holdings PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.91% | $563.99 Million | $7.13 Billion | +4.68pp |
| 2023-12-31 | 3.23% | $186.25 Million | $5.77 Billion | +0.07pp |
| 2022-12-31 | 3.16% | $167.40 Million | $5.30 Billion | -20.23pp |
| 2021-12-31 | 23.39% | $1.46 Billion | $6.24 Billion | +16.77pp |
| 2020-12-31 | 6.62% | $276.62 Million | $4.18 Billion | +0.72pp |
| 2019-12-31 | 5.90% | $221.62 Million | $3.76 Billion | -1.09pp |
| 2018-12-31 | 6.99% | $239.91 Million | $3.43 Billion | +6.69pp |
| 2017-12-31 | 0.29% | $9.15 Million | $3.11 Billion | -2.84pp |
| 2016-12-31 | 3.14% | $95.58 Million | $3.05 Billion | -- |
About Integrated Diagnostics Holdings PLC
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more